Omnicell Appoints Baird Radford as New CFO, Replaces Nchacha Etta.

Omnicell, a leader in transforming pharmacy and nursing care delivery, has appointed Baird Radford as Executive Vice President and Chief Financial Officer, effective August 26, 2025. Radford brings over 30 years of experience driving growth for healthcare and technology companies. He succeeds Nchacha Etta, who will remain with the Company in an advisory role through November 2025.

Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming pharmacy and nursing care delivery, has appointed Baird Radford as Executive Vice President and Chief Financial Officer (CFO), effective August 26, 2025. Mr. Radford brings over 30 years of experience driving growth for healthcare and technology companies. He succeeds Nchacha Etta, who will remain with the Company in an advisory role through November 2025 [1].

Mr. Radford is a seasoned finance executive with extensive experience in strategic and operational finance activities and investor relations. His most recent role was as CFO for Allakos Inc., a biotechnology company focused on developing therapeutic antibodies. Prior to Allakos, he served as Senior Vice President of Finance for Aimmune Therapeutics Inc., which was acquired by Nestle Health Sciences in late 2020, and as CFO for HeartFlow, Inc., an AI health-tech company. He also has leadership roles with Intuitive Surgical, Inc., eBay, Inc., and PricewaterhouseCoopers. Mr. Radford holds a Bachelor of Business Administration degree from Ohio University [1].

Omnicell is committed to transforming pharmacy and nursing care through outcomes-centric solutions designed to deliver clinical and business outcomes across all settings of care. The appointment of Mr. Radford aims to align the Company's financial strategy with its innovation roadmap, positioning it to advance the industry-defined vision of the Autonomous Pharmacy. Omnicell's solutions include robotics, smart devices, intelligent software workflows, data and analytics, and expert services, all optimized to enhance healthcare facilities' efficiency and compliance [1].

Omnicell's Chairman, President, CEO, and Founder, Randall Lipps, expressed his confidence in Mr. Radford's ability to drive the Company's strategy forward. "As we continue our transformation to become a digitally-enabled medication management technology company, Baird’s deep expertise in healthcare and technology growth will be pivotal in aligning our financial strategy with our innovation roadmap," said Lipps [1].

The appointment of Mr. Radford is part of Omnicell's ongoing efforts to ensure a smooth transition and maintain the Company's strategic focus. Nchacha Etta will continue to advise the Company until November 2025 to facilitate a seamless handover of responsibilities [1].

References:
[1] https://www.morningstar.com/news/business-wire/20250825147622/omnicell-appoints-baird-radford-as-executive-vice-president-and-chief-financial-officer
[2] https://www.stocktitan.net/news/OPRX/optimize-rx-corporation-announces-leadership-team-advancements-to-oav64uszmcea.html